David J Tsoulis
Overview
Explore the profile of David J Tsoulis including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
307
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chowdhury D, Chin L, Odabashian R, Fawaz A, Canil C, Ong M, et al.
Cancers (Basel)
. 2025 Jan;
17(2).
PMID: 39858032
The landscape of available therapeutic options for treatment of genitourinary (GU) cancers is expanding dramatically. Many of these treatments have distinct, sometimes severe, skin toxicities including morbilliform, bullous, pustular, lichenoid,...
2.
Tsoulis D, Ghazarian D, Piliotis E, Walsh S
Am J Med
. 2016 Oct;
130(3):e103-e104.
PMID: 27687069
No abstract available.
3.
Chande N, Patton P, Tsoulis D, Thomas B, MacDonald J
Cochrane Database Syst Rev
. 2015 Oct;
(10):CD000067.
PMID: 26517527
Background: The therapeutic role of 6-mercaptopurine (6-MP) and azathioprine (AZA) remains controversial due to their perceived relatively slow-acting effect and adverse effects. An updated meta-analysis was performed to evaluate the...
4.
Mosli M, MacDonald J, Bickston S, Behm B, Tsoulis D, Cheng J, et al.
Inflamm Bowel Dis
. 2015 Apr;
21(5):1151-9.
PMID: 25844963
Background: We performed a systematic review to evaluate the efficacy and safety of vedolizumab for induction and maintenance of remission in ulcerative colitis. Methods: A literature search to June 2014...
5.
Bickston S, Behm B, Tsoulis D, Cheng J, MacDonald J, Khanna R, et al.
Cochrane Database Syst Rev
. 2014 Aug;
(8):CD007571.
PMID: 25105240
Background: Cellular adhesion molecules play an important role in the pathogenesis of ulcerative colitis, making selective blockade of these molecules a promising therapeutic strategy. Vedolizumab, a recombinant humanized IgG1 monoclonal...
6.
McDonald J, Wang Y, Tsoulis D, MacDonald J, Feagan B
Cochrane Database Syst Rev
. 2014 Aug;
(8):CD003459.
PMID: 25099640
Background: Although corticosteroids are effective for induction of remission of Crohn's disease, many patients relapse when steroids are withdrawn or become steroid dependent. Furthermore, corticosteroids exhibit significant adverse effects. The...
7.
Chande N, Tsoulis D, MacDonald J
Cochrane Database Syst Rev
. 2013 May;
(4):CD000545.
PMID: 23633304
Background: The results from controlled clinical trials investigating the efficacy of azathioprine and 6-mercaptopurine for the treatment of active Crohn's disease have been conflicting and controversial. An updated meta-analysis was...
8.
McDonald J, Tsoulis D, MacDonald J, Feagan B
Cochrane Database Syst Rev
. 2012 Dec;
12:CD003459.
PMID: 23235598
Background: Although corticosteroids are effective for induction of remission of Crohn's disease, many patients relapse when steroids are withdrawn or become steroid dependent. Furthermore, corticosteroids exhibit significant adverse effects. The...
9.
Timmer A, McDonald J, Tsoulis D, MacDonald J
Cochrane Database Syst Rev
. 2012 Sep;
(9):CD000478.
PMID: 22972046
Background: Maintenance of remission is a major issue in inflammatory bowel disease. In ulcerative colitis, the evidence for the effectiveness of azathioprine and 6-mercaptopurine for the maintenance of remission is...